Lupin Ltd Quarterly Result

Lupin Ltd Quarterly Result

Image

Lupin Ltd

NSE: LUPIN

Net Profit - Last Quarter

₹ 1416.98 Cr.

Last updated on: Sep 18, 2026

Lupin Ltd Quarterly Results Key Highlights

  • The revenue of Lupin Ltd for the Jun '26 is ₹ 8407 crore as compare to the Mar '26 revenue of ₹ 7615 crore.
  • This represent the growth of 10.4% The ebitda of Lupin Ltd for the Jun '26 is ₹ 2579 crore as compare to the Mar '26 ebitda of ₹ 2494 crore.
  • This represent the growth of 3.4% The net profit of Lupin Ltd for the Jun '26 is ₹ 1416 crore as compare to the Mar '26 net profit of ₹ 1468 crore.
  • This represent the decline of -3.52%.

Lupin Ltd Quarterly Results Analysis

Market Price of Lupin Ltd

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Sep 20262092
16 Sep 20262047.2
15 Sep 20262055.35
11 Sep 20262096
10 Sep 20262075
09 Sep 20262092
08 Sep 20262112
07 Sep 20262105
04 Sep 20262111
03 Sep 20262135

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical EBITDA of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Lupin Ltd News Hub

Lupin launches Mirabegron Extended-Release Tablets in US

 Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, aft

Read more

04 Sept 24

Lupin Ltd soars 2.88%

Lupin Ltd is up for a third straight session in a row. The stock is quoting at Rs 2109.95, up 2.88%

Read more

09 Aug 24

Broader mkt rallies; metal shares advance

The benchmark indices continued to trade with strong gains in mid-morning trade. The Nifty traded ab

Read more

07 Aug 24

Lupin hits 52-week high after Q1 PAT climbs 76% YoY to Rs 801 cr in FY25

Revenue from operations increased 16.28% YoY to Rs 5,514.34 crore during the quarter. Profit before

Read more

07 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Jan 2023

PPT

Jan 2022

PPT

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions